Breaking
Friday, June 19, 2026

Licensing

🇺🇸 FDA Page 2

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Unlock global pharma market opportunities. Get expert insights on drug licensing deals, IP strategies, and M&A trends for strategic BD.

Showing 13–24 of 59 articles

High impact NewsJun 4, 2026

Fierce Biotech Week 2026: Key Insights and Highlights

FDA · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

House bill aims to crack down on China biotech deals

5 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

ASCO Summit: Ivonescimab's China Lung Data Shows Promise, But Global Validation Remains Key

lung · 8 min

Dr. Sarah Mitchell
High impact NewsJun 3, 2026

Vir Biotechnology Stock: Board Reshuffle and Governance Votes Post-AGM

FDA · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

STAT+ R&D Performance Ranking: Insights for Pharma Companies

FDA · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

TrumpRx's Generic Drug Expansion: Strategic Implications for the Pharmaceutical Industry

FDA · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

Eli Lilly and Ascidian Therapeutics Forge RNA Exon Editing Alliance for Genetic Kidney Diseases

genetic kidney diseases · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

Opinion: How the military may be fueling eating disorders in men

eating disorders · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 3, 2026

FDA Approves Xocova: A Catalyst for Pharmaceutical M&A and Licensing

FDA · 8 min

Dr. Sarah Mitchell
High impact NewsJun 3, 2026

Hanmi Signs Licensing Deal with Eli Lilly for Sonefpeglutide, Bolstering GLP-2 Pipeline

FDA · 4 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Sun Pharma and Organon File HSR, Awaiting Antitrust Clearance

7 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Kazia Therapeutics Appoints James Levine as Chief Financial Officer

oncology · 7 min

Dr. Sarah Mitchell